Clevermed Limited - Accounts to registrar (filleted) - small 22.3

Clevermed Limited - Accounts to registrar (filleted) - small 22.3


IRIS Accounts Production v22.3.3.48 03899440 Board of Directors Board of Directors Board of Directors 1.4.21 31.3.22 31.3.22 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure038994402021-03-31038994402022-03-31038994402021-04-012022-03-31038994402020-03-31038994402020-04-012021-03-31038994402021-03-3103899440ns16:EnglandWales2021-04-012022-03-3103899440ns15:PoundSterling2021-04-012022-03-3103899440ns11:Director12021-04-012022-03-3103899440ns11:Director22021-04-012022-03-3103899440ns11:Director32021-04-012022-03-3103899440ns11:PrivateLimitedCompanyLtd2021-04-012022-03-3103899440ns11:SmallEntities2021-04-012022-03-3103899440ns11:AuditExempt-NoAccountantsReport2021-04-012022-03-3103899440ns11:SmallCompaniesRegimeForDirectorsReport2021-04-012022-03-3103899440ns11:SmallCompaniesRegimeForAccounts2021-04-012022-03-3103899440ns11:FullAccounts2021-04-012022-03-3103899440ns11:CompanySecretary12021-04-012022-03-3103899440ns11:RegisteredOffice2021-04-012022-03-3103899440ns6:CurrentFinancialInstruments2022-03-3103899440ns6:CurrentFinancialInstruments2021-03-3103899440ns6:ShareCapital2022-03-3103899440ns6:ShareCapital2021-03-3103899440ns6:CapitalRedemptionReserve2022-03-3103899440ns6:CapitalRedemptionReserve2021-03-3103899440ns6:RetainedEarningsAccumulatedLosses2022-03-3103899440ns6:RetainedEarningsAccumulatedLosses2021-03-3103899440ns6:PlantMachinery2021-03-3103899440ns6:PlantMachinery2021-04-012022-03-3103899440ns6:PlantMachinery2022-03-3103899440ns6:PlantMachinery2021-03-3103899440ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3103899440ns6:WithinOneYearns6:CurrentFinancialInstruments2021-03-3103899440ns6:WithinOneYear2022-03-3103899440ns6:WithinOneYear2021-03-3103899440ns6:BetweenOneFiveYears2022-03-3103899440ns6:BetweenOneFiveYears2021-03-3103899440ns6:AllPeriods2022-03-3103899440ns6:AllPeriods2021-03-3103899440ns11:Director112021-03-3103899440ns11:Director112020-03-3103899440ns11:Director112021-04-012022-03-3103899440ns11:Director112020-04-012021-03-3103899440ns11:Director112022-03-3103899440ns11:Director112021-03-31
REGISTERED NUMBER: 03899440 (England and Wales)









UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MARCH 2022

FOR

CLEVERMED LIMITED

CLEVERMED LIMITED (REGISTERED NUMBER: 03899440)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2022




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


CLEVERMED LIMITED

COMPANY INFORMATION
for the Year Ended 31 March 2022







DIRECTORS: P Badger
J Stephenson
C Koiak





SECRETARY:





REGISTERED OFFICE: 86-90 Paul St.
3rd Floor
London
EC2A 4NE





REGISTERED NUMBER: 03899440 (England and Wales)





ACCOUNTANTS: Mc Creath & Co Limited
Bank House
20A Strathearn Road
Edinburgh
EH9 2AB

CLEVERMED LIMITED (REGISTERED NUMBER: 03899440)

BALANCE SHEET
31 March 2022

2022 2021
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 45,703 51,720

CURRENT ASSETS
Debtors 5 7,292,291 2,263,406
Cash at bank and in hand 2,221,244 1,119,507
9,513,535 3,382,913
CREDITORS
Amounts falling due within one year 6 8,890,466 2,710,181
NET CURRENT ASSETS 623,069 672,732
TOTAL ASSETS LESS CURRENT
LIABILITIES

668,772

724,452

PROVISIONS FOR LIABILITIES 6,535 9,014
NET ASSETS 662,237 715,438

CAPITAL AND RESERVES
Called up share capital 75 75
Capital redemption reserve 25 25
Retained earnings 662,137 715,338
SHAREHOLDERS' FUNDS 662,237 715,438

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2022.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2022 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

CLEVERMED LIMITED (REGISTERED NUMBER: 03899440)

BALANCE SHEET - continued
31 March 2022


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 December 2022 and were signed on its behalf by:




P Badger - Director J Stephenson - Director




C Koiak - Director


CLEVERMED LIMITED (REGISTERED NUMBER: 03899440)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 March 2022

1. STATUTORY INFORMATION

Clevermed Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


The company's principal place of business is Level 6 Edinburgh Quay, 133 Fountainbridge, Edinburgh, EH3 9QG.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents net invoiced sales of goods and services, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery 33% straight line
Computer equipment 33% straight line
Tenants improvements 33% straight line
Motor Vehicles 25% straight line

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

CLEVERMED LIMITED (REGISTERED NUMBER: 03899440)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2022

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Amounts recoverable on contracts
Amounts recoverable on contracts are stated at the value of turnover attributed to the stage of completion on each individual contract less payments on account received and receivable.

CLEVERMED LIMITED (REGISTERED NUMBER: 03899440)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2022

2. ACCOUNTING POLICIES - continued

Revenue recognition
The Company follows the principles of FRS 102 Section 1A, 'Revenue Recognition', in determining appropriate revenue recognition policies. In principle revenue is recognised to the extent that it is probable that the economic benefits associated with the transaction will flow into the organisation.

Revenue is derived from sales of, and distribution agreements relating to, software licences and professional services (including installation). Revenue is recognised when;
(i) persuasive evidence of an arrangement exists,
(ii) the customer has access and right to use our software,
(iii) the sales price can be reasonably measured, and
(iv) collectability is reasonably assured.

Paid for development work is generally provided on a fixed price basis and as such revenue is recognised based on the percentage completion or delivery of the relevant project. Where percentage completion is used it is estimated based on the total number of hours performed on the project compared to the total number of hours expected to complete the project. Where contracts underlying these projects contain material obligations, revenue is deferred and only recognised when all the obligations under the engagement have been fulfilled.

Revenue from standard licensed products which are not modified to meet the specific requirements of each customer is recognised from the point at which the customer has access and right to use the software. This right to use software will be for the period covered under contract and, as a result, the annuity-based revenue model recognises the licensed software revenue over the life of this contract. This policy is consistent with the Company's products providing customers with a service through the delivery of, and access to, software solutions (Software-as-a-Service ("SaaS")), and results in revenue being recognised over the period that these services are delivered to customers.

Occasionally the business may choose to grant a perpetual licence to use the same SaaS products and where this is the case revenue is again recognised from the point at which the customer has access and right to use the software and over an annuity period of 5 years.

Revenue from all professional services is recognised as the applicable services are provided. Where professional services engagements contain material obligations, revenue is recognised when all the obligations under the engagement have been fulfilled. Where professional services engagements are provided on a fixed price basis, revenue is recognised based on the percentage completion of the relevant engagement. Percentage completion is estimated based on the total number of hours performed on the project compared to the total number of hours expected to complete the project.

Any Software and professional services sold via a distribution agreement will normally follow the above recognition policies.

Should any contracts contain non-standard clauses, revenue recognition will be in accordance with the underlying contractual terms which will normally result in recognition of revenue being deferred until all material obligations are satisfied.

The excess of amounts invoiced over revenue recognised are included in deferred income. If the amount of revenue recognised exceeds the amount invoiced the excess is included within accrued income.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 52 (2021 - 39 ) .

CLEVERMED LIMITED (REGISTERED NUMBER: 03899440)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2022

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2021 696,178
Additions 28,362
Disposals (50,050 )
At 31 March 2022 674,490
DEPRECIATION
At 1 April 2021 644,457
Charge for year 34,380
Eliminated on disposal (50,050 )
At 31 March 2022 628,787
NET BOOK VALUE
At 31 March 2022 45,703
At 31 March 2021 51,721

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Trade debtors 6,421,538 1,664,641
Amounts recoverable on contract 445,199 77,254
Directors' current accounts 258,151 346,726
Tax 76,671 105,458
Prepayments 90,732 69,327
7,292,291 2,263,406

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2022 2021
£    £   
Trade creditors 102,926 194,838
Taxation and social security 1,194,822 348,769
Other creditors 7,592,718 2,166,574
8,890,466 2,710,181

7. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2022 2021
£    £   
Within one year 127,744 170,250
Between one and five years 404,522 340,500
532,266 510,750

CLEVERMED LIMITED (REGISTERED NUMBER: 03899440)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 March 2022

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2022 and 31 March 2021:

2022 2021
£    £   
P Badger
Balance outstanding at start of year 346,726 348,978
Amounts advanced 291,425 323,060
Amounts repaid (380,000 ) (325,312 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 258,151 346,726

Where the loan balance owed by the Director to the Company exceeds £10,000 the company charges interest at the official rate of interest approved by HM Revenue and Customs.